Principal Financial Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,208
| Closed | -$1.31M | – | 2501 |
|
|
2023
Q2 | $1.31M | Buy |
33,208
+1,360
| +4% | +$48K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $775K | Sell |
31,848
-1,857
| -6% | -$40.7K | ﹤0.01% | 1895 |
|
|
2022
Q4 | $722K | Buy |
33,705
+3,321
| +11% | +$70.9K | ﹤0.01% | 1903 |
|
|
2022
Q3 | $545K | Sell |
30,384
-23,225
| -43% | -$305K | ﹤0.01% | 1942 |
|
|
2022
Q2 | $515K | Buy |
53,609
+30,271
| +130% | +$380K | ﹤0.01% | 2053 |
|
|
2022
Q1 | $392K | Sell |
23,338
-1,008
| -4% | -$14.9K | ﹤0.01% | 2175 |
|
|
2021
Q4 | $407K | Buy |
24,346
+12,902
| +113% | +$211K | ﹤0.01% | 2172 |
|
|
2021
Q3 | $186K | Buy |
11,444
+182
| +2% | +$1.98K | ﹤0.01% | 2443 |
|
|
2021
Q2 | $71K | Buy |
+11,262
| New | +$72.7K | ﹤0.01% | 2552 |
|
|
2016
Q4 | – | Sell |
-5,427
| Closed | -$250K | – | 2256 |
|
|
2016
Q3 | $250K | Buy |
5,427
+61
| +1% | +$3.44K | ﹤0.01% | 1989 |
|
|
2016
Q2 | $274K | Buy |
+5,366
| New | +$267K | ﹤0.01% | 1959 |
|
|
2016
Q1 | – | Sell |
-4,104
| Closed | -$322K | – | 2208 |
|
|
2015
Q4 | $322K | Buy |
+4,104
| New | +$237K | ﹤0.01% | 1934 |
|
|
2015
Q3 | – | Sell |
-4,084
| Closed | -$213K | – | 2230 |
|
|
2015
Q2 | $213K | Buy |
+4,084
| New | +$203K | ﹤0.01% | 2030 |
|
Principal Financial Group's ISEE Position: Q3 2023 in Review
Principal Financial Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 33,208 shares — an estimated $1.31M sold.
Principal Financial Group first reported a position in ISEE in Q2 2015 and held it in 13 quarters. The position peaked at $1.31M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Principal Financial Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Principal Financial Group sold 33,208 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.31M.
- Principal Financial Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 13 quarters.
- Principal Financial Group's IVERIC bio, Inc. Common Stock position peaked at $1.31M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Principal Financial Group's 13F filing for Q3 2023, filed 2 Nov 2023.